About
Asthma Therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
4,555
By Phase
PHASE2: 1PHASE3: 4
By Status
ACTIVE_NOT_RECRUITING: 2RECRUITING: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06533553Lead Sponsor
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
PHASE2Active, not recruiting
30 participants
Started: Jul 9, 2024 · Completed: Dec 31, 2025
NCT06388889Lead Sponsor
Phase III Long-Term Extension Study With Dexpramipexole
PHASE3Enrolling by invitation
1,600 participants
Started: Jun 12, 2024 · Completed: May 31, 2028
NCT05813288Lead Sponsor
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
PHASE3Recruiting
930 participants
Started: Mar 27, 2023 · Completed: Feb 28, 2027
NCT05748600Lead Sponsor
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
PHASE3Active, not recruiting
600 participants
Started: Jan 30, 2023 · Completed: Dec 31, 2025
NCT05763121Lead Sponsor
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
PHASE3Recruiting
1,395 participants
Started: Jan 30, 2023 · Completed: May 31, 2027
Locations (1)
Headquarters
Chapel Hill, NC, United States
Map
Loading map...